Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists

Somak Roy, Christopher Coldren, Arivarasan Karunamurthy, Nefize S. Kip, Eric W Klee, Stephen E. Lincoln, Annette Leon, Mrudula Pullambhatla, Robyn L. Temple-Smolkin, Karl V. Voelkerding, Chen Wang, Alexis B. Carter

Research output: Contribution to journalReview article

63 Citations (Scopus)

Abstract

Bioinformatics pipelines are an integral component of next-generation sequencing (NGS). Processing raw sequence data to detect genomic alterations has significant impact on disease management and patient care. Because of the lack of published guidance, there is currently a high degree of variability in how members of the global molecular genetics and pathology community establish and validate bioinformatics pipelines. Improperly developed, validated, and/or monitored pipelines may generate inaccurate results that may have negative consequences for patient care. To address this unmet need, the Association of Molecular Pathology, with organizational representation from the College of American Pathologists and the American Medical Informatics Association, has developed a set of 17 best practice consensus recommendations for the validation of clinical NGS bioinformatics pipelines. Recommendations include practical guidance for laboratories regarding NGS bioinformatics pipeline design, development, and operation, with additional emphasis on the role of a properly trained and qualified molecular professional to achieve optimal NGS testing quality.

Original languageEnglish (US)
Pages (from-to)4-27
Number of pages24
JournalJournal of Molecular Diagnostics
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Molecular Pathology
Computational Biology
Joints
Guidelines
Patient Care
Medical Informatics
American Medical Association
Disease Management
Practice Guidelines
Molecular Biology
Pathologists

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine

Cite this

Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines : A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists. / Roy, Somak; Coldren, Christopher; Karunamurthy, Arivarasan; Kip, Nefize S.; Klee, Eric W; Lincoln, Stephen E.; Leon, Annette; Pullambhatla, Mrudula; Temple-Smolkin, Robyn L.; Voelkerding, Karl V.; Wang, Chen; Carter, Alexis B.

In: Journal of Molecular Diagnostics, Vol. 20, No. 1, 01.01.2018, p. 4-27.

Research output: Contribution to journalReview article

Roy, Somak ; Coldren, Christopher ; Karunamurthy, Arivarasan ; Kip, Nefize S. ; Klee, Eric W ; Lincoln, Stephen E. ; Leon, Annette ; Pullambhatla, Mrudula ; Temple-Smolkin, Robyn L. ; Voelkerding, Karl V. ; Wang, Chen ; Carter, Alexis B. / Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines : A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists. In: Journal of Molecular Diagnostics. 2018 ; Vol. 20, No. 1. pp. 4-27.
@article{41db4af1344b4b999dba22683d7ccaf5,
title = "Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists",
abstract = "Bioinformatics pipelines are an integral component of next-generation sequencing (NGS). Processing raw sequence data to detect genomic alterations has significant impact on disease management and patient care. Because of the lack of published guidance, there is currently a high degree of variability in how members of the global molecular genetics and pathology community establish and validate bioinformatics pipelines. Improperly developed, validated, and/or monitored pipelines may generate inaccurate results that may have negative consequences for patient care. To address this unmet need, the Association of Molecular Pathology, with organizational representation from the College of American Pathologists and the American Medical Informatics Association, has developed a set of 17 best practice consensus recommendations for the validation of clinical NGS bioinformatics pipelines. Recommendations include practical guidance for laboratories regarding NGS bioinformatics pipeline design, development, and operation, with additional emphasis on the role of a properly trained and qualified molecular professional to achieve optimal NGS testing quality.",
author = "Somak Roy and Christopher Coldren and Arivarasan Karunamurthy and Kip, {Nefize S.} and Klee, {Eric W} and Lincoln, {Stephen E.} and Annette Leon and Mrudula Pullambhatla and Temple-Smolkin, {Robyn L.} and Voelkerding, {Karl V.} and Chen Wang and Carter, {Alexis B.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jmoldx.2017.11.003",
language = "English (US)",
volume = "20",
pages = "4--27",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "1",

}

TY - JOUR

T1 - Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines

T2 - A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists

AU - Roy, Somak

AU - Coldren, Christopher

AU - Karunamurthy, Arivarasan

AU - Kip, Nefize S.

AU - Klee, Eric W

AU - Lincoln, Stephen E.

AU - Leon, Annette

AU - Pullambhatla, Mrudula

AU - Temple-Smolkin, Robyn L.

AU - Voelkerding, Karl V.

AU - Wang, Chen

AU - Carter, Alexis B.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Bioinformatics pipelines are an integral component of next-generation sequencing (NGS). Processing raw sequence data to detect genomic alterations has significant impact on disease management and patient care. Because of the lack of published guidance, there is currently a high degree of variability in how members of the global molecular genetics and pathology community establish and validate bioinformatics pipelines. Improperly developed, validated, and/or monitored pipelines may generate inaccurate results that may have negative consequences for patient care. To address this unmet need, the Association of Molecular Pathology, with organizational representation from the College of American Pathologists and the American Medical Informatics Association, has developed a set of 17 best practice consensus recommendations for the validation of clinical NGS bioinformatics pipelines. Recommendations include practical guidance for laboratories regarding NGS bioinformatics pipeline design, development, and operation, with additional emphasis on the role of a properly trained and qualified molecular professional to achieve optimal NGS testing quality.

AB - Bioinformatics pipelines are an integral component of next-generation sequencing (NGS). Processing raw sequence data to detect genomic alterations has significant impact on disease management and patient care. Because of the lack of published guidance, there is currently a high degree of variability in how members of the global molecular genetics and pathology community establish and validate bioinformatics pipelines. Improperly developed, validated, and/or monitored pipelines may generate inaccurate results that may have negative consequences for patient care. To address this unmet need, the Association of Molecular Pathology, with organizational representation from the College of American Pathologists and the American Medical Informatics Association, has developed a set of 17 best practice consensus recommendations for the validation of clinical NGS bioinformatics pipelines. Recommendations include practical guidance for laboratories regarding NGS bioinformatics pipeline design, development, and operation, with additional emphasis on the role of a properly trained and qualified molecular professional to achieve optimal NGS testing quality.

UR - http://www.scopus.com/inward/record.url?scp=85038217746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038217746&partnerID=8YFLogxK

U2 - 10.1016/j.jmoldx.2017.11.003

DO - 10.1016/j.jmoldx.2017.11.003

M3 - Review article

C2 - 29154853

AN - SCOPUS:85038217746

VL - 20

SP - 4

EP - 27

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 1

ER -